| ¿µ¹® | amylase | ÇÑ±Û | ¾Æ¹Ð¶ó¾ÆÁ¦, ¾Æ¹Ð·¹À̽º |
|---|---|---|---|
| ¼³¸í | ´çÀº ´ÙÀ½°ú °°ÀÌ 3°¡Áö·Î ±¸ºÐµÈ´Ù. ´çÀÌ ÇѰ³ÀÎ ´Ü´ç·ù, ´Ü´ç·ù°¡ 3~6Á¤µµ ¿¬°áµÇ¾î ÀÖ´Â ¿Ã¸®°í´ç·ù, ±×¸®°í ¿Ã¸®°í´ç·ù ¿©·¯°³°¡ ¿¬°áµÇ¾î ÀÖ´Â ´Ù´ç·ù°¡ ±×°ÍÀÌ´Ù. ¾Æ¹Ð¶ó¾ÆÁ¦´Â ´Ù´ç·ùÀÇ ¿¬°áÀ» ²÷´Â È¿¼Ò·Î½á ħ°ú ÀÌÀÚ¿¡¼ ºÐºñµÇ´Â ¼ÒȾ׿¡ ¸¹´Ù. ±× ¿Ü¿¡µµ ¿©·¯ °¡Áö Á¶Á÷¿¡ ºÐÆ÷ÇÑ´Ù. ÀÌ È¿¼ÒÀÇ Ç÷Áß ³óµµ´Â ħ»ùÀÇ º´, ƯÈ÷ ħ»ù¿°ÁõÀÌ ÀÖÀ» ¶§ Áõ°¡ÇÏ°í ±Þ¼ºÀÌÀÚ¿°ÀÇ Áø´Ü¿¡µµ µµ¿òÀ» ÁØ´Ù. |
||
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
|---|---|
| ACR | Amylase-Creatinine Clearance Ratio &... |
| MIg | malaria immunoglobulin; measles immunoglobulin; membrane immunoglobulin |
| AIA | allylisopropylacetamide; amylase inhibitor activity; anti-immunoglobulin antibody; anti-insulin anti... |
| APSAC | 1) Acylating the Plasminogen Streptokinase Activated Complex 2) Anisoylat... |
| AMY | Amylase |
|---|---|
| Am | Amylase |
| ACCR | Amylase-creatinine clearance ratio |
| TA-A | Taka-amylase A |
| UA | Urinary amylase |
| alpha-amylase | <enzyme> An enzyme that catalyses the endohydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides containing 3 or more 1,4-alpha-linked d-glucose units. Pharmacological action: anti-inflammatory agents. Chemical name: 1,4-alpha-D-Glucan glucanohydrolase Registry number: EC 3.2.1.1 (12 Dec 1998) |
|---|---|
| amylase | <enzyme> An enzyme produced in the pancreas and salivary glands. Elevation of the blood amylase is common in conditions of pancreatitis. (27 Sep 1997) |
| amylase-creatinine clearance ratio | A test for the diagnosis of acute pancreatitis; it is determined by measuring amylase and creatinine in serum and urine in apparently healthy individuals the renal clearance of amylase is less than 5% that of creatinine; in acute pancreatitis the ratio is said to be greater than 0.05 or 5%. (05 Mar 2000) |
| beta-amylase | <enzyme> An enzyme that catalyses the hydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides so as to remove successive beta-maltose units from the non-reducing ends of the chains. Chemical name: 1,4-alpha-D-Glucan maltohydrolase Registry number: EC 3.2.1.2 (12 Dec 1998) |
| gamma-amylase | A hydrolase removing terminal alpha-1,4-linked d-glucose residues from nonreducing ends of chains, with release of beta-d-glucose. Synonym: acid maltase, amyloglucosidase, gamma-amylase, glucoamylase. (05 Mar 2000) |
| maltotriose-forming amylase | <enzyme> Also carries out transglycosylation, forming p-nitrophenyl alpha-maltotetraoside from maltotetraose and p-nitrophenyl alpha-d-glucopyranoside Registry number: EC 3.2.1.- Synonym: g3-amylase (26 Jun 1999) |
| glycosylated alpha-amylase | <enzyme> Contains a single biantennary n-linked oligosaccharide that terminates with the structure fucalpha1,3(galbeta1,4)glcnac Registry number: EC 3.2.1.- Synonym: human glycosylated alpha-amylase (26 Jun 1999) |
| saccharogen amylase | <enzyme> An enzyme that catalyses the hydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides so as to remove successive beta-maltose units from the non-reducing ends of the chains. Chemical name: 1,4-alpha-D-Glucan maltohydrolase Registry number: EC 3.2.1.2 (12 Dec 1998) |
| anti-D immunoglobulin | rHo(D) immune globulin |
| rabies immunoglobulin | rabies immune globulin (human) |
| genes, immunoglobulin | Genes encoding the light and heavy chain segments of immunoglobulins. Light chain gene segments are symbolised l-v (variable), j (joining) and c (constant); ig heavy chain segments have, in addition, a diversity (d) gene. Each segment codes for certain amino acids, and each has a different nucleotide sequence; the genes are assembled by a remarkable shuffling of the segments during b lymphocyte maturation. (12 Dec 1998) |
| receptors, polymeric immunoglobulin | Specialised fc receptors (receptors, fc) for polymeric immunoglobulins, which mediate transcytosis of polymeric IgA and IgM into external secretions. They are found on the surfaces of epithelial cells and hepatocytes. After binding to IgA, the receptor-ligand complex undergoes endocytosis, transport by vesicle, and secretion into the lumen by exocytosis. Before release, the part of the receptor (secretory component) that is bound to IgA is proteolytically cleaved from its transmembrane tail. (12 Dec 1998) |
| measles immunoglobulin | measles immune globulin (human) |
| cellular immunodeficiency with abnormal immunoglobulin synthesis | An ill-defined group of sporadic disorders of unknown cause, occurring in both males and females and associated with recurrent bacterial, fungal, protozoal, and viral infections; there is thymic hypoplasia with depressed cellular (T-lymphocyte) immunity combined with defective humoral (B-lymphocyte) immunity, although immunoglobulin levels may be normal. Synonym: Nezelof syndrome, Nezelof type of thymic alymphoplasia. (05 Mar 2000) |
| Rho(D) immunoglobulin | rHo(D) immune globulin |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|